Equities

Medical Data Vision Co Ltd

3902:TYO

Medical Data Vision Co Ltd

Actions
Health CareHealth Care Providers
  • Price (JPY)415.00
  • Today's Change2.00 / 0.48%
  • Shares traded397.60k
  • 1 Year change-39.68%
  • Beta1.4108
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments3,2182,2653,222
Total Receivables, Net1,1209811,056
Total Inventory6.081411
Prepaid expenses------
Other current assets, total319265236
Total current assets4,6623,5254,525
Property, plant & equipment, net159138140
Goodwill, net90257222
Intangibles, net0.812.255.28
Long term investments69041035
Note receivable - long term------
Other long term assets276241298
Total assets6,2214,8975,535
LIABILITIES
Accounts payable1419397
Accrued expenses5.954.8929
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total1,6591,1091,117
Total current liabilities1,8061,2071,244
Total long term debt000
Total debt000
Deferred income tax------
Minority interest669149
Other liabilities, total998485
Total liabilities1,9701,3821,378
SHAREHOLDERS EQUITY
Common stock993993993
Additional paid-in capital1,8391,8391,764
Retained earnings (accumulated deficit)3,7993,0462,880
Treasury stock - common(2342)(2342)(1479)
Unrealized gain (loss)(37)(20)--
Other equity, total0.00--0.00
Total equity4,2513,5164,157
Total liabilities & shareholders' equity6,2214,8975,535
Total common shares outstanding383839
Treasury shares - common primary issue1.831.831.07
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.